| Patent application number | Description | Published |
|---|
| 20080213843 | Glucoamylase Variants - The invention relates to a variant of a parent fungal glucoamylase, which exhibits altered properties, in particular improved thermal stability and/or increased specific activity. | 09-04-2008 |
| 20090082246 | Amylase Variants - The present invention relates to variants (mutants) of polypeptides, in particular Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits an alteration in at least one of the following properties relative to said parent alpha-amylase: substrate specificity, substrate binding, substrate cleavage pattern, thermal stability, pH/activity profile, pH/stability profile, stability towards oxidation, Ca | 03-26-2009 |
| 20090317864 | Alpha-Amylase Mutants - The invention relates to a novel Termamyl-like alpha-amylase, and Termamyl-like alpha-amylases comprising mutations in two, three, four, five or six regions/positions. The variants have increased thermostability at acidic pH and/or at low Ca | 12-24-2009 |
| 20100173844 | Stable Formulations of Peptides - Stable pharmaceutical composition comprising insulinotropic peptide. | 07-08-2010 |
| Patent application number | Description | Published |
|---|
| 20080234381 | Novel Trifluoromethoxy-Substituted Aryl Anilides - The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful in the treatment, including prevention, of obesity, diabetes and a number of diseases or disorders associated therewith. | 09-25-2008 |
| 20090062396 | Novel Haloalkoxy-Substituted Salicylic Anilides - The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful in the treatment, including prevention, of obesity, diabetes and a number of diseases or disorders associated therewith. | 03-05-2009 |
| 20090325941 | NOVEL 2-(2-HYDROXYPHENYL) BENZOTHIADIAZINES USEFUL FOR TREATING OBESITY AND DIABETES - The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful, inter alia, in the treatment, including prevention, of obesity, diabetes and a number of diseases or conditions associated therewith. | 12-31-2009 |
| 20100041657 | HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES - The present invention relates to compounds of formula I, in which at least one of R5, R6 and R7 is SR12, S(O)R12 or S(O)2R12 group where R12 is a C1-6haloalkyl group, that act, as chemical uncouplers. Compounds of the invention are useful in the treatment, including prevention, of obesity, diabetes and a number of diseases or conditions associated therewith. | 02-18-2010 |
| 20100063122 | NOVEL 2-(2-HYDROXYPHENYL)BENZIMlDAZOLES USEFUL FOR TREATING OBESITY AND DIABETES - The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful, inter alia, in the treatment, including prevention, of obesity, diabetes and a number of diseases or conditions associated therewith. | 03-11-2010 |
| 20100113536 | HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES - The present invention relates to novel compounds of formula [I], wherein R | 05-06-2010 |
| 20100249161 | 2- ( 2 -HYDROXYPHENYL) -QUINAZOLIN-4-ONES USEFUL FOR TREATING OBESITY AND DIABETES - The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful, inter alia, in the treatment, including prevention, of obesity, diabetes and a number of diseases or conditions associated therewith. | 09-30-2010 |
| Patent application number | Description | Published |
|---|
| 20090059942 | METHOD AND APPARATUS FOR SCHEDULING PACKETS AND/OR CELLS - A system and method of scheduling packets or cells for a switch device that includes a plurality of input ports each having at least one input queue, a plurality of switch units, and a plurality of output ports. There is generated, by each input port having a packet or cell in its at least one queue, a request to output the corresponding packet or cell to each of the output ports to which a corresponding packet or cell is to be sent to, wherein the request includes a specific one of the plurality of switch units to be used in a transfer of the packet or cell from the corresponding input port to the corresponding output port. Access is granted, per output port per switch unit, to the request made on a first priority scheme. Grants are accepted per input port per switch unit, the accepting being based on a second priority scheme. Packets and/or cells are outputted from the respective input ports to the respective output ports, based on the accepted grants, utilizing the corresponding switch units identified in the accepted grants. | 03-05-2009 |
| 20100232449 | Method and Apparatus For Scheduling Packets and/or Cells - A system and method of switching data using a switch device that includes a plurality of input ports, a plurality of switch units, and a plurality of output ports. Each input port storing data to be sent may generate a request to output data to each of the output ports to which stored data is to be sent, wherein each request identifies a specific one of the plurality of switch units to be used to transfer the data from the corresponding input port to the corresponding output port. Grants may be generated per output port per switch unit. Grants may be accepted per input port per switch unit. Data may be outputted from the respective input ports to the respective output ports, based on the accepted grants, utilizing the switch units identified in the requests corresponding to the accepted grants. | 09-16-2010 |
| Patent application number | Description | Published |
|---|
| 20080234633 | Injection Device - An injection device ( | 09-25-2008 |
| 20090012479 | Injection Device with an End of Dose Feedback Mechanism - An injection device with a dose delivering mechanism being adapted to provide a non-visual, e.g. audible and/or tactile, feedback signal when a set dose has been at least substantially injected. A first and a second part of the injection device are adapted to perform a relative rotational movement with respect to each other. The relative rotational movement causes at least two parts of the injection device to abut or engage, and this abutment or engagement causes the non-visual feedback signal to be generated. A very distinct and precise feedback is provided as compared to prior art axial solutions because the generation of the feedback signal is initiated by the relative rotational movement. Feedback signal may be generated by a change in a rotational velocity of at least one part, e.g. by changing the pitch of a threaded portion or by engaging a non-rotating part and a rotating part, thereby causing the non-rotating part to start rotating. May alternatively be generated by building up and releasing a tension. The injection device is suitable for injecting insulin. | 01-08-2009 |
| 20090254043 | Coupling for Injection Devices - The present invention concerns a prefilled injection device having a container and a dose setting mechanism encapsulated inside the housing. The housing is made from two parts which are locked together by a bayonet coupling: In addition to the bayonet coupling, the two parts are also provided with irreversible locking means locking the two parts permanently together. | 10-08-2009 |
| 20100324499 | Injection Device - An injection device with a travelling clutch which can be shifted between two different positions by the activation of an injection button. In the first position, the injection button and the driver is allowed to rotate relatively to the piston rod, which is blocked from rotation by the clicker element. In the second position, the drive sleeve and the injection button is axially movable while the piston rod is allowed to rotate. | 12-23-2010 |
